CANC

Tema Oncology ETF

Feb 25 • 04:00PM ET

37.71

-0.24 -0.64 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	46.83%	Total Holdings	56	Perf Week	2.20%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	160.39M	Perf Month	3.29%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	9.33%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	38.03 -0.84%	Perf Half Y	43.14%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 87.65%	Perf YTD	8.61%
Active/Passive		Quant Type		Tags	-	Flows% 1M	8.66%	Volatility	1.60% 1.80%	Perf Year	47.25%
Dividend TTM	0.02 (0.05%)	ESG Type		Tags	-	Flows% 3M	44.38%	ATR (14)	0.73	Perf 3Y	-
Dividend Ex-Date	Dec 10, 2025	Dividend Type		Sector/Theme		Flows% YTD	25.80%	RSI (14)	61.39	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.95	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	2.93%	Flows% 3Y		Rel Volume	0.59	Prev Close	37.95
Inverse/Leveraged		Market Cap		SMA50	4.63%	Flows% 5Y		Avg Volume	38.22K	Price	37.71
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	25.86%	Trades		Volume	22,522	Change	-0.64%

Jan-09-26 10:00AM	Here's Why Biotech ETFs Are Rallying Hard (Zacks)
Dec-02-25 06:00AM	Temas Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance (Business Wire)
Nov-26-25 10:00AM	Be Thankful to These ETFs This Year (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience